Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases-Reference-Cited by-同舟云学术

Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases

Published:2020-11 Issue:4 Volume: Page:1302-1306
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Andreev-Drakhlin Alexander¹,Cabanillas Maria¹,Amini Behrang¹,Subbiah Vivek¹

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00096

Reference18 articles.

1. Brain metastasis from medullary thyroid carcinoma

2. Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer

3. Management of brain metastases from thyroid carcinoma

4. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

5. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rearranged during transfection (RET) inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

2. Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications;The Chemical Record;2023-11-27

3. Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review;Cancer Investigation;2023-09-14

4. Intracranial Activity of Selpercatinib in Chinese Patients With AdvancedRETFusion–Positive Non–Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial;JCO Precision Oncology;2023-09

5. The efficacy and safety of selective RET inhibitors in RET fusion-positive non-small cell lung cancer: a meta-analysis;Investigational New Drugs;2023-08-21